Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.

Kazuhiro NishikawaWasaburo KoizumiAkira TsuburayaTakeharu YamanakaSatoshi MoritaKazumasa FujitaniYusuke AkamaruKen ShimadaHisashi HosakaNorisuke NakayamaToshimasa TsujinakaJunichi Sakamoto

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2019)

UMIN 000025367.

Keyphrases

phase iii
open label
double blind
systematic review
placebo controlled
clinical trial
phase ii
meta analyses
neoadjuvant chemotherapy
study protocol
randomized controlled trial
squamous cell carcinoma
combination therapy
lymph node